Healthcare Change and Innovation
This page provides a centralized source for Moody's research on key credit issues relating to healthcare. 
  • SUMMARY
  • REPORTS

  • TOPIC PAGE
    23 Apr 2020|Moody's Investors Service
    The coronavirus outbreak is disrupting economies and credit markets worldwide. The impact on issuers’ credit profiles and the economy will depend on the severity and duration of the crisis.

    SECTOR IN-DEPTH
    12 Feb 2020|Moody's Investors Service
    Spread of the coronavirus in China and beyond would have mixed credit implications for US healthcare companies. While the outbreak could hamper medical device and pharmaceutical companies that manufacture or source products in China, it could also ultimately increase demand for hospital services, medical products and devices, and certain drugs.
    SECTOR IN-DEPTH
    23 Jan 2020|Moody's Investors Service
    Newer, innovative procedures like TAVR will remain a meaningful portion of overall medical device sales, offsetting pricing pressure in mature categories, like stents.

    SECTOR COMMENT
    16 Dec 2019|Moody's Investors Service
    The rising cost of healthcare and the growing uninsured population underlie the challenges to affordability and access for households, fueling the high social risks for the healthcare sector

    Podcast
    19 Nov 2019|Moody's Investors Service
    Robard Williams and Rebecca Karnovitz of the Credit Strategy & Research team discuss proposals that would expand access and affordability of health insurance in the US. The proposals, if enacted, would be positive for household consumption and many consumer-facing sectors but be negative for the healthcare sector and would increase fiscal risks for the US sovereign.​
    0:00
    0:00